{"transactions":[{"id":677705,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-08-24T21:06:57.000Z","date":"2026-08-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":25729,"price":0.672,"value":17289.888,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units (\"RSUs\") granted to the reporting person on May 20, 2024, March 21, 2025 and March 20, 2026, which grants were originally reported on Form 3 and Form 4s filed with the U.S. Securities and Exchange Commission on September 3, 2024, March 24, 2025 and April 8, 2026."}],"balance_after":1480823,"source":{"system":"sec-edgar","filing":"0001193125-26-363767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526363767/ownership.xml","form_type":"4"}},{"id":729453,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-06-23T21:45:02.000Z","date":"2026-06-20","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"), 40% of which will vest on June 20, 2027, and the remaining 60% of which will vest on June 20, 2028 subject to the Reporting Person's continued service to the Company through the applicable vesting dates. Each RSU represents the right to receive one share of common stock upon vesting."}],"balance_after":1506552,"source":{"system":"sec-edgar","filing":"0001193125-26-279833","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526279833/ownership.xml","form_type":"4"}},{"id":766477,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-05-22T21:17:30.000Z","date":"2026-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":25729,"price":1,"value":25729.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024, March 21, 2025 and March 20, 2026, which grants were originally reported on Form 3 and Form 4s filed with the U.S. Securities and Exchange Commission on September 3, 2024,  March 24, 2025 and April 8, 2026, respectively."}],"balance_after":1006552,"source":{"system":"sec-edgar","filing":"0001193125-26-237182","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526237182/ownership.xml","form_type":"4"}},{"id":812807,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Business Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2026-04-09T01:55:04.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":612240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option becomes exercisable as to 1/16th of the underlying shares on May 20, 2026, with the remaining shares vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":612240,"derivative":{"exercise_price":0.9846,"expiration_date":"2036-03-20","underlying":"Common Stock","underlying_shares":612240},"source":{"system":"sec-edgar","filing":"0001193125-26-148614","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526148614/ownership.xml","form_type":"4"}},{"id":812806,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-04-09T01:55:04.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":272107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest over four years, with 1/16 of the RSUs vesting on May 20, 2026 and the remaining RSUs vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."}],"balance_after":1032281,"source":{"system":"sec-edgar","filing":"0001193125-26-148614","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526148614/ownership.xml","form_type":"4"}},{"id":885548,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-02-24T22:44:23.000Z","date":"2026-02-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":19661,"price":1.15,"value":22610.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024 and March 21, 2025, which grants were originally reported on Form 3 and Form 4 filed with the U.S. Securities and Exchange Commission on September 3, 2024 and March 24, 2025, respectively."}],"balance_after":760174,"source":{"system":"sec-edgar","filing":"0001193125-26-067638","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526067638/ownership.xml","form_type":"4"}},{"id":990452,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-11-24T22:03:50.000Z","date":"2025-11-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":19661,"price":1.28,"value":25166.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024 and March 21, 2025, which grants were originally reported on Form 3 and Form 4 filed with the U.S. Securities and Exchange Commission on September 3, 2024 and March 24, 2025, respectively."}],"balance_after":779835,"source":{"system":"sec-edgar","filing":"0001193125-25-293841","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312525293841/ownership.xml","form_type":"4"}},{"id":1058520,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-08-22T21:45:36.000Z","date":"2025-08-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":19661,"price":1.27,"value":24969.47,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024 and March 21, 2025, which grants were originally reported on Form 3 and Form 4 filed with the U.S. Securities and Exchange Commission on September 3, 2024 and March 24, 2025, respectively."}],"balance_after":799496,"source":{"system":"sec-edgar","filing":"0001193125-25-186506","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312525186506/ownership.xml","form_type":"4"}},{"id":1129584,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-05-30T21:52:17.000Z","date":"2025-05-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":23919,"price":1.09,"value":26071.71,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on March 21, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 24, 2025."}],"balance_after":819157,"source":{"system":"sec-edgar","filing":"0000950170-25-079890","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025079890/ownership.xml","form_type":"4"}},{"id":1132266,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-05-28T21:52:31.000Z","date":"2025-05-23","kind":"sale","planned":false,"acquired":false,"shares":13217,"price":0.941,"value":12437.197,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to satisfy the tax obligations that arose upon the vesting of restricted stock units granted to the reporting person on March 21, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission (\"SEC\") on March 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $0.92 to $0.9748 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer."}],"balance_after":843076,"source":{"system":"sec-edgar","filing":"0000950170-25-078463","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025078463/ownership.xml","form_type":"4"}},{"id":1135742,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-05-23T22:13:16.000Z","date":"2025-05-22","kind":"sale","planned":false,"acquired":false,"shares":12536,"price":1.002,"value":12561.072,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to satisfy the tax obligations that arose upon the vesting of restricted stock units granted to the reporting person on March 21, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission (\"SEC\") on March 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $0.9403 to $1.03 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer."}],"balance_after":856293,"source":{"system":"sec-edgar","filing":"0000950170-25-077191","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025077191/ownership.xml","form_type":"4"}},{"id":1135741,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-05-23T22:13:16.000Z","date":"2025-05-21","kind":"sale","planned":false,"acquired":false,"shares":12838,"price":1.03,"value":13223.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to satisfy the tax obligations that arose upon the vesting of restricted stock units granted to the reporting person on March 21, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission (\"SEC\") on March 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $1.015 to $1.05 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer."}],"balance_after":868829,"source":{"system":"sec-edgar","filing":"0000950170-25-077191","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025077191/ownership.xml","form_type":"4"}},{"id":1193827,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-24T22:37:24.000Z","date":"2025-03-21","kind":"grant","planned":false,"acquired":true,"shares":422500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option becomes exercisable as to 1/16th of the underlying shares on May 20, 2025, with the remaining shares vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":422500,"derivative":{"exercise_price":1.21,"expiration_date":"2035-03-21","underlying":"Common Stock","underlying_shares":422500},"source":{"system":"sec-edgar","filing":"0000950170-25-044011","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025044011/ownership.xml","form_type":"4"}},{"id":1193826,"issuer":{"id":6116,"kind":"organization","name":"STANDARD BIOTOOLS INC."},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-03-24T22:37:24.000Z","date":"2025-03-21","kind":"grant","planned":false,"acquired":true,"shares":281667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest over four years, with 1/16th of the RSUs vesting on May 20, 2025 and the remaining RSUs vesting in equally quarterly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting."}],"balance_after":881667,"source":{"system":"sec-edgar","filing":"0000950170-25-044011","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025044011/ownership.xml","form_type":"4"}},{"id":1943301,"issuer":{"id":115290,"kind":"organization","name":"IsoPlexis Corp","symbol":"ISO"},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2023-03-21T20:47:35.000Z","date":"2023-03-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":296100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 21, 2023, pursuant to the Merger Agreement, each IsoPlexis stock option (whether vested or unvested) reported in this Form 4 (a) if the per-share exercise price was equal to or greater than the average closing trading price for a share of IsoPlexis Common Stock rounded to the nearest one-tenth of a cent, as reported on The Nasdaq Stock Market LLC for the five most recent trading days ending on and including the third business day prior to March 20, 2023 (the Company Trading Price), was canceled for no consideration and (b) if the per-share exercise price was less than the Company Trading Price, was converted into a Berkeley Lights stock option of approximately equivalent value and generally on the same terms and conditions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F16","text":"Vests 25% on March 31, 2023 and thereafter in 36 equal monthly installments."}],"balance_after":0,"derivative":{"exercise_price":3.43,"expiration_date":"2032-03-31","underlying":"Common Stock","underlying_shares":296100},"source":{"system":"sec-edgar","filing":"0001062993-23-007401","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1875501/000106299323007401/form4.xml","form_type":"4"}},{"id":1943300,"issuer":{"id":115290,"kind":"organization","name":"IsoPlexis Corp","symbol":"ISO"},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2023-03-21T20:47:35.000Z","date":"2023-03-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":744000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 21, 2023, pursuant to the Merger Agreement, each IsoPlexis stock option (whether vested or unvested) reported in this Form 4 (a) if the per-share exercise price was equal to or greater than the average closing trading price for a share of IsoPlexis Common Stock rounded to the nearest one-tenth of a cent, as reported on The Nasdaq Stock Market LLC for the five most recent trading days ending on and including the third business day prior to March 20, 2023 (the Company Trading Price), was canceled for no consideration and (b) if the per-share exercise price was less than the Company Trading Price, was converted into a Berkeley Lights stock option of approximately equivalent value and generally on the same terms and conditions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F15","text":"Vested 25% on June 8, 2020 and thereafter in 36 equal monthly installments."}],"balance_after":0,"derivative":{"exercise_price":4.81,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":744000},"source":{"system":"sec-edgar","filing":"0001062993-23-007401","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1875501/000106299323007401/form4.xml","form_type":"4"}},{"id":1943299,"issuer":{"id":115290,"kind":"organization","name":"IsoPlexis Corp","symbol":"ISO"},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2023-03-21T20:47:35.000Z","date":"2023-03-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":680000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 21, 2023, pursuant to the Merger Agreement, each IsoPlexis stock option (whether vested or unvested) reported in this Form 4 (a) if the per-share exercise price was equal to or greater than the average closing trading price for a share of IsoPlexis Common Stock rounded to the nearest one-tenth of a cent, as reported on The Nasdaq Stock Market LLC for the five most recent trading days ending on and including the third business day prior to March 20, 2023 (the Company Trading Price), was canceled for no consideration and (b) if the per-share exercise price was less than the Company Trading Price, was converted into a Berkeley Lights stock option of approximately equivalent value and generally on the same terms and conditions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"Vested in full as of December 15, 2020."}],"balance_after":0,"derivative":{"exercise_price":1.0275,"expiration_date":"2030-04-18","underlying":"Common Stock","underlying_shares":680000},"source":{"system":"sec-edgar","filing":"0001062993-23-007401","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1875501/000106299323007401/form4.xml","form_type":"4"}},{"id":1943298,"issuer":{"id":115290,"kind":"organization","name":"IsoPlexis Corp","symbol":"ISO"},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2023-03-21T20:47:35.000Z","date":"2023-03-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":96000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 21, 2023, pursuant to the Merger Agreement, each IsoPlexis stock option (whether vested or unvested) reported in this Form 4 (a) if the per-share exercise price was equal to or greater than the average closing trading price for a share of IsoPlexis Common Stock rounded to the nearest one-tenth of a cent, as reported on The Nasdaq Stock Market LLC for the five most recent trading days ending on and including the third business day prior to March 20, 2023 (the Company Trading Price), was canceled for no consideration and (b) if the per-share exercise price was less than the Company Trading Price, was converted into a Berkeley Lights stock option of approximately equivalent value and generally on the same terms and conditions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"Vested 25% on December 5, 2019 and thereafter in 36 equal monthly installments."}],"balance_after":0,"derivative":{"exercise_price":0.9625,"expiration_date":"2028-12-13","underlying":"Common Stock","underlying_shares":96000},"source":{"system":"sec-edgar","filing":"0001062993-23-007401","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1875501/000106299323007401/form4.xml","form_type":"4"}},{"id":1943297,"issuer":{"id":115290,"kind":"organization","name":"IsoPlexis Corp","symbol":"ISO"},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2023-03-21T20:47:35.000Z","date":"2023-03-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 21, 2023, pursuant to the Merger Agreement, each IsoPlexis stock option (whether vested or unvested) reported in this Form 4 (a) if the per-share exercise price was equal to or greater than the average closing trading price for a share of IsoPlexis Common Stock rounded to the nearest one-tenth of a cent, as reported on The Nasdaq Stock Market LLC for the five most recent trading days ending on and including the third business day prior to March 20, 2023 (the Company Trading Price), was canceled for no consideration and (b) if the per-share exercise price was less than the Company Trading Price, was converted into a Berkeley Lights stock option of approximately equivalent value and generally on the same terms and conditions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Vested 25% on September 27, 2019 and thereafter in 36 equal monthly installments."}],"balance_after":0,"derivative":{"exercise_price":0.7263,"expiration_date":"2028-09-26","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001062993-23-007401","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1875501/000106299323007401/form4.xml","form_type":"4"}},{"id":1943296,"issuer":{"id":115290,"kind":"organization","name":"IsoPlexis Corp","symbol":"ISO"},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2023-03-21T20:47:35.000Z","date":"2023-03-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":52000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 21, 2023, pursuant to the Merger Agreement, each IsoPlexis stock option (whether vested or unvested) reported in this Form 4 (a) if the per-share exercise price was equal to or greater than the average closing trading price for a share of IsoPlexis Common Stock rounded to the nearest one-tenth of a cent, as reported on The Nasdaq Stock Market LLC for the five most recent trading days ending on and including the third business day prior to March 20, 2023 (the Company Trading Price), was canceled for no consideration and (b) if the per-share exercise price was less than the Company Trading Price, was converted into a Berkeley Lights stock option of approximately equivalent value and generally on the same terms and conditions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Vested 25% on June 29, 2019 and thereafter in 36 equal monthly installments."}],"balance_after":0,"derivative":{"exercise_price":0.7263,"expiration_date":"2028-06-28","underlying":"Common Stock","underlying_shares":52000},"source":{"system":"sec-edgar","filing":"0001062993-23-007401","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1875501/000106299323007401/form4.xml","form_type":"4"}},{"id":1943295,"issuer":{"id":115290,"kind":"organization","name":"IsoPlexis Corp","symbol":"ISO"},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2023-03-21T20:47:35.000Z","date":"2023-03-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":48000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 21, 2023, pursuant to the Merger Agreement, each IsoPlexis stock option (whether vested or unvested) reported in this Form 4 (a) if the per-share exercise price was equal to or greater than the average closing trading price for a share of IsoPlexis Common Stock rounded to the nearest one-tenth of a cent, as reported on The Nasdaq Stock Market LLC for the five most recent trading days ending on and including the third business day prior to March 20, 2023 (the Company Trading Price), was canceled for no consideration and (b) if the per-share exercise price was less than the Company Trading Price, was converted into a Berkeley Lights stock option of approximately equivalent value and generally on the same terms and conditions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Vested 25% on August 1, 2018 and thereafter in 36 equal monthly installments."}],"balance_after":0,"derivative":{"exercise_price":0.7263,"expiration_date":"2028-02-11","underlying":"Common Stock","underlying_shares":48000},"source":{"system":"sec-edgar","filing":"0001062993-23-007401","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1875501/000106299323007401/form4.xml","form_type":"4"}},{"id":1943294,"issuer":{"id":115290,"kind":"organization","name":"IsoPlexis Corp","symbol":"ISO"},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2023-03-21T20:47:35.000Z","date":"2023-03-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":24000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 21, 2023, pursuant to the Merger Agreement, each IsoPlexis stock option (whether vested or unvested) reported in this Form 4 (a) if the per-share exercise price was equal to or greater than the average closing trading price for a share of IsoPlexis Common Stock rounded to the nearest one-tenth of a cent, as reported on The Nasdaq Stock Market LLC for the five most recent trading days ending on and including the third business day prior to March 20, 2023 (the Company Trading Price), was canceled for no consideration and (b) if the per-share exercise price was less than the Company Trading Price, was converted into a Berkeley Lights stock option of approximately equivalent value and generally on the same terms and conditions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Vested 25% on January 16, 2019 and thereafter in 36 equal monthly installments."}],"balance_after":0,"derivative":{"exercise_price":0.7263,"expiration_date":"2028-01-15","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001062993-23-007401","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1875501/000106299323007401/form4.xml","form_type":"4"}},{"id":1943293,"issuer":{"id":115290,"kind":"organization","name":"IsoPlexis Corp","symbol":"ISO"},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2023-03-21T20:47:35.000Z","date":"2023-03-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":112000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 21, 2023, pursuant to the Merger Agreement, each IsoPlexis stock option (whether vested or unvested) reported in this Form 4 (a) if the per-share exercise price was equal to or greater than the average closing trading price for a share of IsoPlexis Common Stock rounded to the nearest one-tenth of a cent, as reported on The Nasdaq Stock Market LLC for the five most recent trading days ending on and including the third business day prior to March 20, 2023 (the Company Trading Price), was canceled for no consideration and (b) if the per-share exercise price was less than the Company Trading Price, was converted into a Berkeley Lights stock option of approximately equivalent value and generally on the same terms and conditions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Vested 25% on October 5, 2018 and thereafter in 36 equal monthly installments."}],"balance_after":0,"derivative":{"exercise_price":0.7263,"expiration_date":"2027-10-04","underlying":"Common Stock","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001062993-23-007401","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1875501/000106299323007401/form4.xml","form_type":"4"}},{"id":1943292,"issuer":{"id":115290,"kind":"organization","name":"IsoPlexis Corp","symbol":"ISO"},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2023-03-21T20:47:35.000Z","date":"2023-03-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":14000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 21, 2023, pursuant to the Merger Agreement, each IsoPlexis stock option (whether vested or unvested) reported in this Form 4 (a) if the per-share exercise price was equal to or greater than the average closing trading price for a share of IsoPlexis Common Stock rounded to the nearest one-tenth of a cent, as reported on The Nasdaq Stock Market LLC for the five most recent trading days ending on and including the third business day prior to March 20, 2023 (the Company Trading Price), was canceled for no consideration and (b) if the per-share exercise price was less than the Company Trading Price, was converted into a Berkeley Lights stock option of approximately equivalent value and generally on the same terms and conditions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Vests 25% one year after achievement of sale target and thereafter in 36 equal monthly installments."}],"balance_after":0,"derivative":{"exercise_price":0.7263,"expiration_date":"2027-10-04","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001062993-23-007401","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1875501/000106299323007401/form4.xml","form_type":"4"}},{"id":1943291,"issuer":{"id":115290,"kind":"organization","name":"IsoPlexis Corp","symbol":"ISO"},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2023-03-21T20:47:35.000Z","date":"2023-03-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":14000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 21, 2023, pursuant to the Merger Agreement, each IsoPlexis stock option (whether vested or unvested) reported in this Form 4 (a) if the per-share exercise price was equal to or greater than the average closing trading price for a share of IsoPlexis Common Stock rounded to the nearest one-tenth of a cent, as reported on The Nasdaq Stock Market LLC for the five most recent trading days ending on and including the third business day prior to March 20, 2023 (the Company Trading Price), was canceled for no consideration and (b) if the per-share exercise price was less than the Company Trading Price, was converted into a Berkeley Lights stock option of approximately equivalent value and generally on the same terms and conditions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Vested 25% on December 26, 2019 upon achievement of performance target and thereafter in 36 equal monthly installments."}],"balance_after":0,"derivative":{"exercise_price":0.7263,"expiration_date":"2027-10-04","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001062993-23-007401","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1875501/000106299323007401/form4.xml","form_type":"4"}},{"id":1943290,"issuer":{"id":115290,"kind":"organization","name":"IsoPlexis Corp","symbol":"ISO"},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2023-03-21T20:47:35.000Z","date":"2023-03-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":52000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 21, 2023, pursuant to the Merger Agreement, each IsoPlexis stock option (whether vested or unvested) reported in this Form 4 (a) if the per-share exercise price was equal to or greater than the average closing trading price for a share of IsoPlexis Common Stock rounded to the nearest one-tenth of a cent, as reported on The Nasdaq Stock Market LLC for the five most recent trading days ending on and including the third business day prior to March 20, 2023 (the Company Trading Price), was canceled for no consideration and (b) if the per-share exercise price was less than the Company Trading Price, was converted into a Berkeley Lights stock option of approximately equivalent value and generally on the same terms and conditions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Vested 25% on October 20, 2017 and thereafter in 36 equal monthly installments."}],"balance_after":0,"derivative":{"exercise_price":0.44,"expiration_date":"2026-10-19","underlying":"Common Stock","underlying_shares":52000},"source":{"system":"sec-edgar","filing":"0001062993-23-007401","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1875501/000106299323007401/form4.xml","form_type":"4"}},{"id":1943289,"issuer":{"id":115290,"kind":"organization","name":"IsoPlexis Corp","symbol":"ISO"},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2023-03-21T20:47:35.000Z","date":"2023-03-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":19000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 21, 2023, pursuant to the Merger Agreement, each IsoPlexis stock option (whether vested or unvested) reported in this Form 4 (a) if the per-share exercise price was equal to or greater than the average closing trading price for a share of IsoPlexis Common Stock rounded to the nearest one-tenth of a cent, as reported on The Nasdaq Stock Market LLC for the five most recent trading days ending on and including the third business day prior to March 20, 2023 (the Company Trading Price), was canceled for no consideration and (b) if the per-share exercise price was less than the Company Trading Price, was converted into a Berkeley Lights stock option of approximately equivalent value and generally on the same terms and conditions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vested 25% on May 25, 2017 and thereafter in 36 equal monthly installments."}],"balance_after":0,"derivative":{"exercise_price":0.2788,"expiration_date":"2025-10-31","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001062993-23-007401","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1875501/000106299323007401/form4.xml","form_type":"4"}},{"id":1943288,"issuer":{"id":115290,"kind":"organization","name":"IsoPlexis Corp","symbol":"ISO"},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2023-03-21T20:47:35.000Z","date":"2023-03-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":834,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 21, 2023, pursuant to the Merger Agreement, each IsoPlexis stock option (whether vested or unvested) reported in this Form 4 (a) if the per-share exercise price was equal to or greater than the average closing trading price for a share of IsoPlexis Common Stock rounded to the nearest one-tenth of a cent, as reported on The Nasdaq Stock Market LLC for the five most recent trading days ending on and including the third business day prior to March 20, 2023 (the Company Trading Price), was canceled for no consideration and (b) if the per-share exercise price was less than the Company Trading Price, was converted into a Berkeley Lights stock option of approximately equivalent value and generally on the same terms and conditions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vested 25% on August 31, 2019 and thereafter in 36 equal monthly installments."}],"balance_after":0,"derivative":{"exercise_price":0.2788,"expiration_date":"2025-10-31","underlying":"Common Stock","underlying_shares":834},"source":{"system":"sec-edgar","filing":"0001062993-23-007401","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875501/000106299323007401/form4.xml","form_type":"4"}},{"id":1943287,"issuer":{"id":115290,"kind":"organization","name":"IsoPlexis Corp","symbol":"ISO"},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-21T20:47:35.000Z","date":"2023-03-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":914366,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 21, 2023, pursuant to the Agreement and Plan of Merger, dated as of December 21, 2022 (the Merger Agreement), by and among IsoPlexis Corporation, a Delaware corporation (IsoPlexis), Berkeley Lights, Inc., a Delaware corporation (Berkeley Lights), and Iceland Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Berkeley Lights, each share of common stock, par value $0.001, of IsoPlexis (IsoPlexis Common Stock) reported in this Form 4 was converted into the right to receive 0.6120 fully paid and nonassessable shares of common stock, par value $0.00005, of Berkeley Lights (Berkeley Lights Common Stock), together with cash in lieu of fractional shares of Berkeley Lights Common Stock, if any, and any unpaid dividends or other distributions."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001062993-23-007401","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875501/000106299323007401/form4.xml","form_type":"4"}},{"id":2172045,"issuer":{"id":115290,"kind":"organization","name":"IsoPlexis Corp","symbol":"ISO"},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-08-29T15:08:40.000Z","date":"2022-08-25","kind":"purchase","acquired":true,"shares":15000,"price":1.99,"value":29850.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $1.91 to $2.15, inclusive.  The reporting person undertakes to provide the issuer, any security holder, or the staff of the SEC, upon request, full information with respect to the foregoing."}],"balance_after":914366,"source":{"system":"sec-edgar","filing":"0001062993-22-018820","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875501/000106299322018820/form4.xml","form_type":"4"}},{"id":2177100,"issuer":{"id":115290,"kind":"organization","name":"IsoPlexis Corp","symbol":"ISO"},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2022-08-22T14:21:29.000Z","date":"2022-08-19","kind":"exercise","acquired":false,"shares":61000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options were subject to four-year vesting schedule with 25% vested on May 25, 2017 and the remainder vested in 36 equal monthly installments thereafter."}],"balance_after":19000,"derivative":{"exercise_price":0.2788,"expiration_date":"2025-10-31","underlying":"Common Stock","underlying_shares":61000},"source":{"system":"sec-edgar","filing":"0001062993-22-018546","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1875501/000106299322018546/form4.xml","form_type":"4"}},{"id":2177099,"issuer":{"id":115290,"kind":"organization","name":"IsoPlexis Corp","symbol":"ISO"},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2022-08-22T14:21:29.000Z","date":"2022-08-19","kind":"exercise","acquired":false,"shares":39166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options subject to four-year vesting schedule with 25% vested on August 31, 2019 and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":834,"derivative":{"exercise_price":0.2788,"expiration_date":"2025-10-31","underlying":"Common Stock","underlying_shares":39166},"source":{"system":"sec-edgar","filing":"0001062993-22-018546","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1875501/000106299322018546/form4.xml","form_type":"4"}},{"id":2177098,"issuer":{"id":115290,"kind":"organization","name":"IsoPlexis Corp","symbol":"ISO"},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-08-22T14:21:29.000Z","date":"2022-08-19","kind":"exercise","acquired":true,"shares":61000,"price":0.2788,"value":17006.8,"ownership":{"direct":true},"balance_after":899366,"source":{"system":"sec-edgar","filing":"0001062993-22-018546","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875501/000106299322018546/form4.xml","form_type":"4"}},{"id":2177097,"issuer":{"id":115290,"kind":"organization","name":"IsoPlexis Corp","symbol":"ISO"},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-08-22T14:21:29.000Z","date":"2022-08-19","kind":"exercise","acquired":true,"shares":39166,"price":0.2788,"value":10919.4808,"ownership":{"direct":true},"balance_after":838366,"source":{"system":"sec-edgar","filing":"0001062993-22-018546","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875501/000106299322018546/form4.xml","form_type":"4"}},{"id":2308777,"issuer":{"id":115290,"kind":"organization","name":"IsoPlexis Corp","symbol":"ISO"},"owners":[{"id":20482,"kind":"person","name":"Mackay Sean","position":1,"cik":"0001875501","reported_name":"Mackay Sean","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2022-04-04T15:09:12.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":296100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests 25% on first anniversary of grant date and thereafter in 36 equal monthly installments."}],"balance_after":296100,"derivative":{"exercise_price":3.43,"expiration_date":"2032-03-31","underlying":"Common Stock","underlying_shares":296100},"source":{"system":"sec-edgar","filing":"0001062993-22-009306","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875501/000106299322009306/form4.xml","form_type":"4"}}]}